Annual Operating Expenses
$198.90 M
+$3.54 M+1.81%
31 December 2023
Summary:
TG Therapeutics annual total operating expenses is currently $198.90 million, with the most recent change of +$3.54 million (+1.81%) on 31 December 2023. During the last 3 years, it has fallen by -$74.85 million (-27.34%). TGTX annual operating expenses is now -43.28% below its all-time high of $350.67 million, reached on 31 December 2021.TGTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$62.10 M
+$5.76 M+10.22%
30 September 2024
Summary:
TG Therapeutics quarterly total operating expenses is currently $62.10 million, with the most recent change of +$5.76 million (+10.22%) on 30 September 2024. Over the past year, it has increased by +$14.58 million (+30.68%). TGTX quarterly operating expenses is now -34.67% below its all-time high of $95.06 million, reached on 31 December 2021.TGTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TGTX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.8% | +30.7% |
| 3 y3 years | -27.3% | -28.5% |
| 5 y5 years | +13.9% | +2.0% |
TGTX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -43.3% | +1.8% | -34.7% | +77.2% |
| 5 y | 5 years | -43.3% | +17.6% | -34.7% | +77.2% |
| alltime | all time | -43.3% | >+9999.0% | -34.7% | +3616.4% |
TG Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $62.10 M(+10.2%) |
| June 2024 | - | $56.35 M(-16.3%) |
| Mar 2024 | - | $67.30 M(+38.5%) |
| Dec 2023 | $198.90 M(+1.8%) | $48.60 M(+2.3%) |
| Sept 2023 | - | $47.52 M(-19.2%) |
| June 2023 | - | $58.84 M(+33.9%) |
| Mar 2023 | - | $43.94 M(-15.7%) |
| Dec 2022 | $195.36 M(-44.3%) | $52.14 M(+48.7%) |
| Sept 2022 | - | $35.05 M(-11.3%) |
| June 2022 | - | $39.51 M(-42.4%) |
| Mar 2022 | - | $68.65 M(-27.8%) |
| Dec 2021 | $350.67 M(+28.1%) | $95.06 M(+9.4%) |
| Sept 2021 | - | $86.87 M(+10.1%) |
| June 2021 | - | $78.89 M(-12.2%) |
| Mar 2021 | - | $89.86 M(+3.5%) |
| Dec 2020 | $273.75 M(+61.8%) | $86.82 M(+1.2%) |
| Sept 2020 | - | $85.76 M(+68.5%) |
| June 2020 | - | $50.88 M(+1.2%) |
| Mar 2020 | - | $50.28 M(+32.3%) |
| Dec 2019 | $169.21 M(-3.1%) | $38.00 M(-37.6%) |
| Sept 2019 | - | $60.90 M(+71.2%) |
| June 2019 | - | $35.58 M(+2.5%) |
| Mar 2019 | - | $34.73 M(-35.9%) |
| Dec 2018 | $174.55 M(+46.9%) | $54.19 M(+57.7%) |
| Sept 2018 | - | $34.37 M(-22.6%) |
| June 2018 | - | $44.38 M(+6.7%) |
| Mar 2018 | - | $41.62 M(+33.9%) |
| Dec 2017 | $118.86 M(+50.2%) | $31.07 M(-1.7%) |
| Sept 2017 | - | $31.62 M(+11.1%) |
| June 2017 | - | $28.46 M(+2.7%) |
| Mar 2017 | - | $27.70 M(+15.1%) |
| Dec 2016 | $79.12 M(+24.9%) | $24.07 M(-3.6%) |
| Sept 2016 | - | $24.96 M(+55.4%) |
| June 2016 | - | $16.06 M(+14.5%) |
| Mar 2016 | - | $14.03 M(-20.6%) |
| Dec 2015 | $63.33 M(+13.3%) | $17.68 M(+27.5%) |
| Sept 2015 | - | $13.86 M(-19.2%) |
| June 2015 | - | $17.15 M(+17.1%) |
| Mar 2015 | - | $14.64 M(-22.0%) |
| Dec 2014 | $55.87 M(+175.0%) | $18.76 M(+7.3%) |
| Sept 2014 | - | $17.48 M(+45.7%) |
| June 2014 | - | $11.99 M(+56.9%) |
| Mar 2014 | - | $7.64 M(+46.5%) |
| Dec 2013 | $20.32 M(-21.3%) | $5.22 M(+11.3%) |
| Sept 2013 | - | $4.69 M(-29.7%) |
| June 2013 | - | $6.67 M(+77.7%) |
| Mar 2013 | - | $3.75 M(+44.0%) |
| Dec 2012 | $25.81 M(+2826.2%) | $2.60 M(-4.0%) |
| Sept 2012 | - | $2.71 M(-12.6%) |
| June 2012 | - | $3.10 M(-82.1%) |
| Mar 2012 | - | $17.39 M(+3033.1%) |
| Dec 2011 | $882.00 K(-56.3%) | $554.90 K(+1743.5%) |
| Sept 2011 | - | $30.10 K(-89.9%) |
| June 2011 | - | $297.00 K(-98.4%) |
| Mar 2011 | - | $18.27 M(+3990.3%) |
| Dec 2010 | $2.02 M | $446.60 K(-13.4%) |
| Sept 2010 | - | $515.60 K(-1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $525.10 K(-0.8%) |
| Mar 2010 | - | $529.40 K(+55.1%) |
| Dec 2009 | $1.77 M(-59.9%) | $341.30 K(-13.7%) |
| Sept 2009 | - | $395.60 K(-17.1%) |
| June 2009 | - | $477.30 K(-14.4%) |
| Mar 2009 | - | $557.30 K(-1165.6%) |
| Dec 2008 | $4.41 M(-63.7%) | -$52.30 K(-103.8%) |
| Sept 2008 | - | $1.38 M(-5.7%) |
| June 2008 | - | $1.47 M(-9.1%) |
| Mar 2008 | - | $1.61 M(-15.9%) |
| Dec 2007 | $12.14 M(+21.4%) | $1.92 M(-29.1%) |
| Sept 2007 | - | $2.71 M(-45.0%) |
| June 2007 | - | $4.92 M(+89.8%) |
| Mar 2007 | - | $2.59 M(-18.4%) |
| Dec 2006 | $10.00 M(-48.3%) | $3.18 M(+61.8%) |
| Sept 2006 | - | $1.97 M(-16.6%) |
| June 2006 | - | $2.36 M(-5.6%) |
| Mar 2006 | - | $2.50 M(-82.8%) |
| Dec 2005 | $19.36 M(+215.1%) | $14.53 M(+680.4%) |
| Sept 2005 | - | $1.86 M(+23.3%) |
| June 2005 | - | $1.51 M(+3.6%) |
| Mar 2005 | - | $1.46 M(-18.7%) |
| Dec 2004 | $6.14 M(+29.1%) | $1.79 M(-20.1%) |
| Sept 2004 | - | $2.24 M(+127.2%) |
| June 2004 | - | $986.70 K(-12.1%) |
| Mar 2004 | - | $1.12 M(-26.2%) |
| Dec 2003 | $4.76 M(+367.3%) | $1.52 M(-25.4%) |
| Sept 2003 | - | $2.04 M(+162.4%) |
| June 2003 | - | $777.00 K(+84.0%) |
| Mar 2003 | - | $422.20 K(-163.2%) |
| Dec 2002 | $1.02 M(-72.8%) | -$668.30 K(-213.6%) |
| Sept 2002 | - | $588.20 K(+136.4%) |
| June 2002 | - | $248.80 K(-60.5%) |
| Mar 2002 | - | $629.60 K(+12.8%) |
| Dec 2001 | $3.74 M(-16.3%) | $558.20 K(-20.8%) |
| Sept 2001 | - | $704.50 K(-40.2%) |
| June 2001 | - | $1.18 M(+33.8%) |
| Mar 2001 | - | $880.70 K(-149.9%) |
| Dec 2000 | $4.46 M(+43.9%) | -$1.77 M(-247.6%) |
| Sept 2000 | - | $1.20 M(-64.8%) |
| June 2000 | - | $3.40 M(+110.8%) |
| Mar 2000 | - | $1.61 M(+101.7%) |
| Dec 1999 | $3.10 M(-47.5%) | $800.00 K(+33.3%) |
| Sept 1999 | - | $600.00 K(-14.3%) |
| June 1999 | - | $700.00 K(-30.0%) |
| Mar 1999 | - | $1.00 M(-33.3%) |
| Dec 1998 | $5.90 M(+7.3%) | $1.50 M(+15.4%) |
| Sept 1998 | - | $1.30 M(-23.5%) |
| June 1998 | - | $1.70 M(+21.4%) |
| Mar 1998 | - | $1.40 M(-17.6%) |
| Dec 1997 | $5.50 M(+103.7%) | $1.70 M(+54.5%) |
| Sept 1997 | - | $1.10 M(-38.9%) |
| June 1997 | - | $1.80 M(+100.0%) |
| Mar 1997 | - | $900.00 K(>+9900.0%) |
| Dec 1996 | $2.70 M | $0.00(-100.0%) |
| Sept 1996 | - | $1.20 M(+71.4%) |
| June 1996 | - | $700.00 K |
FAQ
- What is TG Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for TG Therapeutics?
- What is TG Therapeutics annual operating expenses year-on-year change?
- What is TG Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for TG Therapeutics?
- What is TG Therapeutics quarterly operating expenses year-on-year change?
What is TG Therapeutics annual total operating expenses?
The current annual operating expenses of TGTX is $198.90 M
What is the all time high annual operating expenses for TG Therapeutics?
TG Therapeutics all-time high annual total operating expenses is $350.67 M
What is TG Therapeutics annual operating expenses year-on-year change?
Over the past year, TGTX annual total operating expenses has changed by +$3.54 M (+1.81%)
What is TG Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of TGTX is $62.10 M
What is the all time high quarterly operating expenses for TG Therapeutics?
TG Therapeutics all-time high quarterly total operating expenses is $95.06 M
What is TG Therapeutics quarterly operating expenses year-on-year change?
Over the past year, TGTX quarterly total operating expenses has changed by +$14.58 M (+30.68%)